ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia

被引：0
|
作者：
J Menezes
R N Salgado
F Acquadro
G Gómez-López
M C Carralero
A Barroso
F Mercadillo
L Espinosa-Hevia
J G Talavera-Casañas
D G Pisano
S Álvarez
J C Cigudosa
机构：
[1] Molecular Cytogenetics Group,
[2] Human Cancer Genetics Program,undefined
[3] Spanish National Cancer Research Center–CNIO,undefined
[4] Madrid,undefined
[5] Spain,undefined
[6] Bioinformatic Unit,undefined
[7] Structural Biology and Biocomputing Program,undefined
[8] Spanish National Cancer Research Center–CNIO,undefined
[9] Human Genetics Group,undefined
[10] Human Cancer Genetics Program,undefined
[11] Spanish National Cancer Research Center–CNIO,undefined
[12] Clinic Familial Cancer Unit,undefined
[13] Human Cancer Genetics Program,undefined
[14] Spanish National Cancer Research Center–CNIO,undefined
[15] Hematology and Hemotherapy Service,undefined
[16] Ntra. Sra. de Candelaria Hospital,undefined
来源：
Blood Cancer Journal | 2013年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e157 / e157
相关论文
共 50 条
  • [1] ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
    Menezes, J.
    Salgado, R. N.
    Acquadro, F.
    Gomez-Lopez, G.
    Carralero, M. C.
    Barroso, A.
    Mercadillo, F.
    Espinosa-Hevia, L.
    Talavera-Casanas, J. G.
    Pisano, D. G.
    Alvarez, S.
    Cigudosa, J. C.
    BLOOD CANCER JOURNAL, 2013, 3 : e157 - e157
  • [2] Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
    Aram Bidikian
    Hagop Kantarjian
    Elias Jabbour
    Nicholas J. Short
    Keyur Patel
    Farhad Ravandi
    Koji Sasaki
    Ghayas C. Issa
    Blood Cancer Journal, 12
  • [3] Impact of ASXL1 Mutations on Prognosis of Chronic Phase Chronic Myeloid Leukemia
    Bidikian, Aram
    Kantarjian, Hagop
    Jabbour, Elias
    Short, Nicholas
    Ravandi, Farhad
    Issa, Ghayas
    Sasaki, Koji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S291 - S291
  • [4] Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
    Bidikian, Aram
    Kantarjian, Hagop
    Jabbour, Elias
    Short, Nicholas J.
    Patel, Keyur
    Ravandi, Farhad
    Sasaki, Koji
    Issa, Ghayas C.
    BLOOD CANCER JOURNAL, 2022, 12 (10)
  • [5] Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
    Ernst, Thomas
    Busch, Melinda
    Rinke, Jenny
    Ernst, Jana
    Haferlach, Claudia
    Beck, James F.
    Hochhaus, Andreas
    Gruhn, Bernd
    LEUKEMIA, 2018, 32 (09) : 2046 - 2049
  • [6] Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
    Thomas Ernst
    Melinda Busch
    Jenny Rinke
    Jana Ernst
    Claudia Haferlach
    James F. Beck
    Andreas Hochhaus
    Bernd Gruhn
    Leukemia, 2018, 32 : 2046 - 2049
  • [7] Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia
    Braun, Theodore
    Foley, Amy
    Druker, Brian J.
    Maxson, Julia E.
    BLOOD, 2018, 132
  • [8] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    Almorox Rebeca, Bailen
    Gonzalez Julia, Suarez
    Carolina, Martinez-Laperche
    Noemi, Fernandez-Escalada
    Maria, Chicano-Lavilla
    Diego, Carbonell
    Patricia, Font
    Santiago, Osorio
    Jose Lui, Diez-Martin
    Ismael, Buno
    HAEMATOLOGICA, 2016, 101 : 153 - 154
  • [9] Characterization of Chronic Myelomonocytic Leukemia with TP53 mutations
    Wang, Wei
    Routbort, Mark
    Loghavi, Sanam
    Tang, Zhenya
    Medeiros, L. Jeffrey
    Wang, Sa
    MODERN PATHOLOGY, 2018, 31 : 563 - 563
  • [10] Characterization of Chronic Myelomonocytic Leukemia with TP53 mutations
    Wang, Wei
    Routbort, Mark
    Loghavi, Sanam
    Tang, Zhenya
    Medeiros, L. Jeffrey
    Wang, Sa
    LABORATORY INVESTIGATION, 2018, 98 : 563 - 563
12345